We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
66 hedge funds and large institutions have $88.5M invested in Cardiff Oncology in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
375% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 8
300% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 5
93% more capital invested
Capital invested by funds: $45.8M → $88.5M (+$42.7M)
83% more funds holding
Funds holding: 36 → 66 (+30)
69% less call options, than puts
Call options by funds: $407K | Put options by funds: $1.33M
Holders
66
Holders Change
+30
Holders Change %
+83.33%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
38
Increased
20
Reduced
5
Closed
8
Calls
$407K
Puts
$1.33M
Net Calls
-$924K
Net Calls Change
-$748K
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.72M |
| 2 |
Goldman Sachs
New York
|
+$3.05M |
| 3 |
BM
Bridger Management
New York
|
+$2.96M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$2.86M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.86M |
Top Sellers
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$4.43M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.05M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$2.21M |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$1.16M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$334K |
